Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
BMC Sports Science, Medicine & Rehabilitation
|
April 30, 2025
Physical fitness predicts post-esophagectomy complications after chemoradiotherapy: a pilot study
Chien-Hung Chiu, Wei-Yang Chang, Lan-Yan Yang, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
Management and Prognosis of Patients with Recurrent or Persistent/Progressive Uterine Carcinosarcoma
Hsiu-Jung Tung, Chi-Yuan Chiang, Wei-Yang Chang, et al.
Journal of the Chinese Medical Association : JCMA
|
November 8, 2021
Serum levels of alpha1-antitrypsin isoforms in patients with ovarian clear cell carcinoma: An exploratory study
Sung-Yao Chen, Ting-Chang Chang, Chiao-Yun Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 9, 2017
Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study
Fei-Chun Ku, Ren-Chin Wu, Lan-Yan Yang, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 13, 2021
Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial
Hung-Hsueh Chou, Wei-Chun Chen, Lan-Yan Yang, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 5, 2018
Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma
Angel Chao, Chyong-Huey Lai, Tzu-Hao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 11, 2016
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial
Feng-Yuan Liu, Chyong-Huey Lai, Lan-Yan Yang, et al.
Journal of Gynecologic Oncology
|
January 9, 2020
<i>BRCA1/2</i> mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
Angel Chao, Yi Hao Lin, Lan Yan Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 11, 2019
Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma
Huei-Jean Huang, Lan-Yan Yang, Hsiu-Jung Tung, et al.
Taiwanese Journal of Obstetrics & Gynecology
|
May 20, 2022
Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study
Wei-Chun Chen, Hextan Ys Ngan, Lan-Yan Yang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
BMC Sports Science, Medicine & Rehabilitation
|
April 30, 2025
Physical fitness predicts post-esophagectomy complications after chemoradiotherapy: a pilot study
Chien-Hung Chiu, Wei-Yang Chang, Lan-Yan Yang, et al.
Current Oncology (Toronto, Ont.)
|
October 27, 2022
Management and Prognosis of Patients with Recurrent or Persistent/Progressive Uterine Carcinosarcoma
Hsiu-Jung Tung, Chi-Yuan Chiang, Wei-Yang Chang, et al.
Journal of the Chinese Medical Association : JCMA
|
November 8, 2021
Serum levels of alpha1-antitrypsin isoforms in patients with ovarian clear cell carcinoma: An exploratory study
Sung-Yao Chen, Ting-Chang Chang, Chiao-Yun Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
April 9, 2017
Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study
Fei-Chun Ku, Ren-Chin Wu, Lan-Yan Yang, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
May 13, 2021
Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: A phase II AGOG/TGOG trial
Hung-Hsueh Chou, Wei-Chun Chen, Lan-Yan Yang, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
May 5, 2018
Genomic scar signatures associated with homologous recombination deficiency predict adverse clinical outcomes in patients with ovarian clear cell carcinoma
Angel Chao, Chyong-Huey Lai, Tzu-Hao Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 11, 2016
Utility of (18)F-FDG PET/CT in patients with advanced squamous cell carcinoma of the uterine cervix receiving concurrent chemoradiotherapy: a parallel study of a prospective randomized trial
Feng-Yuan Liu, Chyong-Huey Lai, Lan-Yan Yang, et al.
Journal of Gynecologic Oncology
|
January 9, 2020
<i>BRCA1/2</i> mutation status in patients with metachronous breast and ovarian malignancies: clues towards the implementation of genetic counseling
Angel Chao, Yi Hao Lin, Lan Yan Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 11, 2019
Management and clinical outcomes of patients with recurrent/progressive ovarian clear cell carcinoma
Huei-Jean Huang, Lan-Yan Yang, Hsiu-Jung Tung, et al.
Taiwanese Journal of Obstetrics & Gynecology
|
May 20, 2022
Verification of HPV16 as a good prognostic factor for cervical adeno-adenosquamous carcinoma via an international collaborative study
Wei-Chun Chen, Hextan Ys Ngan, Lan-Yan Yang, et al.
Page
of 3